NeuroOne Medical Technologies Corporation (NMTC) Tops Q2 EPS by 2c ; Offers Guidance

NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) reported Q2 EPS of ($0.07), $0.02 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $1.4 million versus the consensus estimate of $2.4 million.

GUIDANCE:

NeuroOne Medical Technologies Corporation sees FY2025 revenue of $8-10 million, versus the consensus of $8.16 million.

For earnings history and earnings-related data on NeuroOne Medical Technologies Corporation (NMTC) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• Wendy's U.S. president to resign, company to create COO role
• XP Inc eyes US banking license as next business step